Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that non-malignant stem cell transplant patients who received their transplant more than six months ago receive the same priority for the covid-19 vaccine as other stem cell transplant patients.

Priority group 6 includes all those who are defined as clinically vulnerable and at higher risk of serious illness from COVID-19. People who have received a stem cell transplant more than six months ago are included in this definition. People who have received a stem cell transplant within the last six months will be defined as clinically extremely vulnerable (CEV), in which case they are included in priority group 4. Both groups should now have been called forward for vaccination.

Further information can be found at the following links:

https://www.nhs.uk/conditions/coronavirus-covid-19/people-at-higher-risk/who-is-at-high-risk-from-coronavirus-clinically-extremely-vulnerable/

https://www.anthonynolan.org/patients-and-families/understanding-stem-cell-transplants/coronavirus-and-your-stem-cell-transplant